Petri E, Altwein J E
Dtsch Med Wochenschr. 1978 Jan 6;103(1):30-2. doi: 10.1055/s-0028-1104376.
A bladder carcinoma developed in a 40-year-old man who was being treated with trofosfamide (Ixoten), a cyclophosphamide derivative, for Hodgkin's disease. The case suggests the need for differentiated replacement of this group of cytostatics.
一名40岁男性在接受环磷酰胺衍生物曲磷胺（Ixoten）治疗霍奇金病时发生了膀胱癌。该病例提示需要对这类细胞抑制剂进行差异化替代。
